Correlation Between QLI Old and Veritas Pharma

Can any of the company-specific risk be diversified away by investing in both QLI Old and Veritas Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining QLI Old and Veritas Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between QLI Old and Veritas Pharma, you can compare the effects of market volatilities on QLI Old and Veritas Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in QLI Old with a short position of Veritas Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of QLI Old and Veritas Pharma.

Diversification Opportunities for QLI Old and Veritas Pharma

0.0

Correlation Coefficient

QLI Old  Veritas Pharma

Pay attention - limited upside

The 3 months correlation between QLI and Veritas is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding QLI Old and Veritas Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Veritas Pharma and QLI Old is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on QLI Old are associated (or correlated) with Veritas Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Veritas Pharma has no effect on the direction of QLI Old i.e., QLI Old and Veritas Pharma go up and down completely randomly.

Pair Corralation between QLI Old and Veritas Pharma

If you would invest  0.15  in Veritas Pharma on December 29, 2024 and sell it today you would earn a total of  0.00  from holding Veritas Pharma or generate 0.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	0.0%
Values	Daily Returns

QLI Old  vs.  Veritas Pharma

QLI Old

Risk-Adjusted Performance

Very Weak

Over the last 90 days QLI Old has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong essential indicators, QLI Old is not utilizing all of its potentials. The current stock price confusion, may contribute to short-horizon losses for the traders.

Veritas Pharma

Risk-Adjusted Performance

Very Weak

Over the last 90 days Veritas Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable technical indicators, Veritas Pharma is not utilizing all of its potentials. The latest stock price disturbance, may contribute to mid-run losses for the stockholders.

Pair Trading with QLI Old and Veritas Pharma

The main advantage of trading using opposite QLI Old and Veritas Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if QLI Old position performs unexpectedly, Veritas Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Veritas Pharma will offset losses from the drop in Veritas Pharma's long position.

The idea behind QLI Old and Veritas Pharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.